Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Alexander

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesisA C Berger, G Tang, H R Alexander, et al.
Cancer Research|July 23, 1999
Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in miceM F Gnant, M Puhlmann, H R Alexander, et al.
Annals of Surgery|September 24, 1999
Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastasesM F Gnant, M Puhlmann, D L Bartlett, et al.
The Cancer Journal From Scientific American|July 1, 1995
Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factorD L Fraker, H R Alexander, M Andrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation studyD L Fraker, H R Alexander, M Andrich, et al.
The Journal of Surgical Research|April 1, 1993
Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in miceM J McNamara, J A Norton, R J Nauta, et al.
Journal of the American College of Surgeons|November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignanciesS K Libutti, D L Barlett, D L Fraker, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1990
Needle-localized mammographic lesions. Results and evolving treatment strategyH R Alexander, F C Candela, D D Dershaw, et al.
Current Surgery|January 1, 1985
Urinary thromboxane (TxA2) reflects dose-response tissue injury in humansH R Alexander, W R Thompson, P W Ramwell, et al.
European Journal of Nuclear Medicine|November 1, 1995
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbsW C Barker, M P Andrich, H R Alexander, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesisA C Berger, G Tang, H R Alexander, et al.
Cancer Research|July 23, 1999
Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in miceM F Gnant, M Puhlmann, H R Alexander, et al.
Annals of Surgery|September 24, 1999
Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastasesM F Gnant, M Puhlmann, D L Bartlett, et al.
The Cancer Journal From Scientific American|July 1, 1995
Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factorD L Fraker, H R Alexander, M Andrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation studyD L Fraker, H R Alexander, M Andrich, et al.
The Journal of Surgical Research|April 1, 1993
Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in miceM J McNamara, J A Norton, R J Nauta, et al.
Journal of the American College of Surgeons|November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignanciesS K Libutti, D L Barlett, D L Fraker, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1990
Needle-localized mammographic lesions. Results and evolving treatment strategyH R Alexander, F C Candela, D D Dershaw, et al.
Current Surgery|January 1, 1985
Urinary thromboxane (TxA2) reflects dose-response tissue injury in humansH R Alexander, W R Thompson, P W Ramwell, et al.
European Journal of Nuclear Medicine|November 1, 1995
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbsW C Barker, M P Andrich, H R Alexander, et al.
Pageof 14